Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.

Malhi G, Adams D, Plain J, Coulston C, Herman M, Walter G.

Australas Psychiatry. 2010 Feb;18(1):32-41. doi: 10.3109/10398560903254193.

PMID:
20039791
[PubMed - indexed for MEDLINE]
2.

Prevalence of the metabolic syndrome among patients receiving clozapine.

Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB.

Am J Psychiatry. 2006 Jul;163(7):1273-6.

PMID:
16816234
[PubMed - indexed for MEDLINE]
3.

Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.

Brunero S, Lamont S, Fairbrother G.

Arch Psychiatr Nurs. 2009 Jun;23(3):261-8. doi: 10.1016/j.apnu.2008.06.007. Epub 2009 Jan 15.

PMID:
19446781
[PubMed - indexed for MEDLINE]
4.

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

Ahmed M, Hussain I, O'Brien SM, Dineen B, Griffin D, McDonald C.

Ir J Med Sci. 2008 Sep;177(3):205-10. doi: 10.1007/s11845-008-0156-9. Epub 2008 May 7.

PMID:
18461270
[PubMed - indexed for MEDLINE]
5.

Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.

Bai YM, Chen JY, Yang WS, Chi YC, Liou YJ, Lin CC, Wang YC, Lin CY, Su TP, Chou P.

J Clin Psychiatry. 2007 Dec;68(12):1834-9.

PMID:
18162013
[PubMed - indexed for MEDLINE]
6.

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.

Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM.

Am J Psychiatry. 1994 Dec;151(12):1744-52.

PMID:
7977880
[PubMed - indexed for MEDLINE]
7.

Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.

Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA.

J Clin Psychopharmacol. 2008 Apr;28(2):132-7. doi: 10.1097/JCP.0b013e318166c4f7.

PMID:
18344722
[PubMed - indexed for MEDLINE]
8.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
[PubMed - indexed for MEDLINE]
9.

The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.

Lee NY, Roh MS, Kim SH, Jung DC, Yu HY, Sung KH, Chung IW, Youn T, Kang UG, Ahn YM, Kim YS.

Int Clin Psychopharmacol. 2013 Mar;28(2):71-9. doi: 10.1097/YIC.0b013e32835b99bd.

PMID:
23211493
[PubMed - indexed for MEDLINE]
10.

Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

J Clin Psychiatry. 2005 Jul;66(7):900-6.

PMID:
16013906
[PubMed - indexed for MEDLINE]
11.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
12.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
[PubMed - indexed for MEDLINE]
13.

A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.

Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.

Am J Psychiatry. 2001 Aug;158(8):1305-13.

PMID:
11481167
[PubMed - indexed for MEDLINE]
14.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
[PubMed - indexed for MEDLINE]
15.

Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Newcomer JW.

J Clin Psychiatry. 2007;68 Suppl 1:20-7. Review.

PMID:
17286524
[PubMed - indexed for MEDLINE]
16.

The metabolic syndrome and schizophrenia.

Meyer JM, Stahl SM.

Acta Psychiatr Scand. 2009 Jan;119(1):4-14. doi: 10.1111/j.1600-0447.2008.01317.x. Review.

PMID:
19133915
[PubMed - indexed for MEDLINE]
17.

Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.

Bai YM, Lin CC, Chen JY, Chen TT, Su TP, Chou P.

J Clin Psychiatry. 2011 Jun;72(6):751-6. doi: 10.4088/JCP.09m05402yel. Epub 2010 Nov 30.

PMID:
21208584
[PubMed - indexed for MEDLINE]
18.

Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.

Cerit C, Vural M, Bos Gelmez SÜ, Ozten E, Aker AT, Yıldız M.

Psychopharmacol Bull. 2010;43(4):22-36.

PMID:
21240150
[PubMed - indexed for MEDLINE]
19.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
[PubMed - indexed for MEDLINE]
20.

Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?

Remington G.

Am J Psychiatry. 2006 Jul;163(7):1132-4. No abstract available.

PMID:
16816213
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk